Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults.

about

A Review of the Efficacy and Safety of Genvoya(®) (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) in the Management of HIV-1 Infection.Single-Tablet Regimens for the Treatment of HIV-1 Infection.Precision medicine for HIV: where are we?

P2860

Q38756133-96E090BA-5FEF-44F6-8603-8BF749D3EC7C Q39022885-6613F3AE-7FD5-4D42-BAB1-E28D6C97BB09 Q47569821-91AA60DB-3627-40EE-9806-DDBA6CC1D41C

P2860

Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults.

Item

http://www.wikidata.org/entity/Q38661064

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Elvitegravir, cobicistat, emtr ...... he treatment of HIV in adults.

@en

type

Item

label

Elvitegravir, cobicistat, emtr ...... he treatment of HIV in adults.

@en

prefLabel

Elvitegravir, cobicistat, emtr ...... he treatment of HIV in adults.

@en

P1476

Elvitegravir, cobicistat, emtr ...... he treatment of HIV in adults.

@en

P2093

Alice Trentalange

http://www.w3.org/2001/XMLSchema#string

Andrea Calcagno

http://www.w3.org/2001/XMLSchema#string

Giovanni Di Perri

http://www.w3.org/2001/XMLSchema#string

Stefano Bonora

http://www.w3.org/2001/XMLSchema#string

P2860

Cobicistat boosts the intestinal absorption of transport substrates, including HIV protease inhibitors and GS-7340, in vitro

The role of drug transporters in the kidney: lessons from tenofovir

Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?

Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults.

Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue.

Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA, in blood.

Elvitegravir: a once-daily, boosted, HIV-1 integrase inhibitor.

Recommendations for evaluation and management of bone disease in HIV.

Emtricitabine: a new nucleoside analogue for once-daily antiretroviral therapy.

Tenofovir plasma concentrations according to companion drugs: a cross-sectional study of HIV-positive patients with normal renal function.

P304

409-419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2016.1129401

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26642079

http://www.w3.org/2001/XMLSchema#string

Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults.

about

P2860

P2860

Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698